Nicotinamide Riboside for Diabetic Neuropathy

NCT03685253 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Completed the pilot study and grant funding not obtained to continue to the main phase 2 study. The pilot study did not show a statistical significance in the primary or secondary outcome measures.

Conditions

Interventions

Sponsor

University of Maryland, Baltimore

Collaborators